schizophrenia
harmful pattern of use of cocaine, episodic
certain specified alcohol-induced mental or behavioural disorders
schizoaffective disorder, multiple episodes
oppositional defiant disorder, unspecified
circadian rhythm sleep-wake disorder, jet lag type
nicotine dependence, sustained full remission
bipolar type ii disorder, current episode depressive, moderate with psychotic symptoms
insomnia disorders
harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous
functional neurological symptom disorder
trance disorder
dementia due to use of sedatives, hypnotics or anxiolytics
anorexia nervosa with significantly low body weight, binge-purge pattern
major depressive disorder, single and recurrent episodes
other specified sleep-related breathing disorders
alcohol withdrawal, unspecified
other specified disorders due to use of unknown or unspecified psychoactive substances
dissociative neurological symptom disorder, with vertigo or dizziness
disorders due to use of alcohol, unspecified
acute and transient psychotic disorder, first episode, currently symptomatic
episode of harmful use of mdma or related drugs, including mda
mdma or related drug dependence, including mda, sustained partial remission
cocaine-induced obsessive-compulsive or related disorder
obsessive-compulsive disorder with poor to absent insight
autism spectrum disorder, unspecified
dementia due to diseases classified elsewhere
disorders due to use of multiple specified psychoactive substances, including medications
wandering in dementia
substance major or mild neurocognitive disorder
harmful pattern of use of multiple specified psychoactive substances, unspecified
dissociative amnesia without dissociative fugue
other specified harmful pattern of use of synthetic cannabinoids
childhood-onset fluency disorder
paraphilic disorders, unspecified
single episode depressive disorder, unspecified
depressive disorder due to another medical condition
schizoaffective disorder, first episode, in full remission
antisocial personality disorder
harmful pattern of use of dissociative drugs including ketamine or pcp, episodic
autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language
harmful pattern of use of other specified psychoactive substance, unspecified
cannabis dependence, sustained full remission
substance use disorders
bulimia nervosa
unspecified sleep-wake disorder
anorexia nervosa in recovery with normal body weight
central sleep apnoea due to a medical condition with cheyne-stokes breathing
unspecified sedative disorder
congenital central alveolar sleep-related hypoventilation
other specified psychoactive substance dependence, sustained full remission
volatile inhalant-induced mood disorder
disorders due to use of non-psychoactive substances, unspecified
attention deficit hyperactivity disorder, combined presentation
delirium due to psychoactive substances including medications
harmful pattern of use of alcohol, continuous
hoarding disorder
cfi
synthetic cathinone dependence, early full remission
attention deficit hyperactivity disorder
enuresis
catatonia associated with another mental disorder
severe bodily distress disorder
parasomnia disorder due to a medical condition
dissociative drug-induced anxiety disorder including ketamine or pcp
bipolar type i disorder, currently in partial remission, most recent episode manic or hypomanic
other specified disorders due to use of multiple specified psychoactive substances, including medications
other specified depressive disorder
episode of harmful use of multiple specified psychoactive substances
cocaine dependence, sustained partial remission
prolonged grief disorder
volatile inhalant-induced anxiety disorder
nicotine dependence, early full remission
schizophrenia, multiple episodes
episode of harmful use of sedatives, hypnotics or anxiolytics
moderate bodily distress disorder
disorders specifically associated with stress
social anxiety disorder
amnestic disorder due to other specified psychoactive substance including medications
unspecified sexual dysfunction
psychotic symptoms in dementia
trichotillomania
multiple specified psychoactive substances withdrawal
neurocognitive disorders, unspecified
certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders
unspecified cannabis-related disord
detachment in personality disorder or personality difficulty
disruptive mood dysregulation disorder
dementia due to injury to the head
hoarding disorder with poor to absent insight
other specified psychoactive substance dependence, unspecified
bipolar or related disorders, unspecified
sedative, hypnotic or anxiolytic dependence, sustained partial remission
amnestic disorder, unknown or unspecified cause
certain specified dissociative drugs -induced mental or behavioural disorders, including ketamine and phencyclidine [pcp]
other specified paraphilic disorder
neurobehavioral disorder associated with prenatal alcohol exposure
panic attack
opioid dependence, current use
negative affectivity in personality disorder or personality difficulty
harmful pattern of use of non-psychoactive substances, continuous
idiopathic hypersomnia
cocaine dependence
stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission
circadian rhythm sleep-wake disorders, unspecified
inhalant intoxication
disorder of intellectual development, provisional
cannabis intoxication
motor disorders
other specified conduct-dissocial disorder, adolescent onset
schizophrenia or other primary psychotic disorders, unspecified
single episode depressive disorder, unspecified severity
major or mild neurocognitive disorder due to hiv infection
major and mild neurocognitive disorders
mdma or related drug-induced psychotic disorder, including mda
harmful pattern of use of volatile inhalants
synthetic cathinone-induced psychotic disorder with hallucinations
harmful pattern of use of mdma or related drugs, including mda
other specified psychoactive substance withdrawal, with perceptual disturbances and seizures
sleep-wake disorders
other specified tic disorder
recurrent depressive disorder, current episode moderate, with psychotic symptoms
other specified single episode depressive disorder
disorder of intellectual development, profound
female sexual interest/arousal disorder
harmful pattern of use of volatile inhalants, continuous
developmental motor coordination disorder
cocaine dependence, current use
other specified anorexia nervosa
sleep-related movement disorders, unspecified
obsessive-compulsive or related disorder induced by multiple specified psychoactive substances
substance mental disorders
persistent depressive disorder
other specified feeding or eating disorders
dementia due to exposure to heavy metals and other toxins
sedative, hypnotic or anxiolytic dependence, sustained full remission
psychotic disorder induced by other specified psychoactive substance
stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms
alcohol withdrawal
stimulant intoxication including amphetamines, methamphetamine or methcathinone
substance/medication-induced major or mild neurocognitive disorder
avoidant personality disorder
neurodevelopmental disorders
hallucinogen persisting perception disorder
disorders due to use of sedatives, hypnotics or anxiolytics
unspecified obsessive-compulsive and related disorder
schizophrenia, continuous, currently symptomatic
cocaine-induced psychotic disorder with mixed psychotic symptoms
recurrent depressive disorder, current episode severe, without psychotic symptoms
other specified psychoactive substance withdrawal
medication-induced bipolar and related disorder
harmful pattern of use of cannabis, unspecified
medication-induced sleep disorder
narcolepsy
harmful pattern of use of hallucinogens, continuous
stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions
stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone
other specified disorders due to use of other specified psychoactive substances, including medications
attention deficit hyperactivity disorder, other specified presentation
harmful pattern of use of opioids, unspecified
opioid-induced delirium
opioid dependence, unspecified
hypnotic disorders
illness anxiety disorder
other (or unknown) substance intoxication
sleep-wake disorders, unspecified
disinhibition in dementia
schizoaffective disorder, first episode, in partial remission
certain specified volatile inhalants-induced mental or behavioural disorders
stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified
other specified disorders due to use of cocaine
substance psychotic disorder
binge eating disorder
certain specified cannabis-induced mental or behavioural disorders
psychomotor symptoms in primary psychotic disorders
withdrawal due to unknown or unspecified psychoactive substance, unspecified
feeding or eating disorders, unspecified
secondary impulse control syndrome
unspecified communication disorder
binge-eating disorder
harmful pattern of use of synthetic cathinones, unspecified
cocaine-induced impulse control disorder
kleptomania
recurrent depressive disorder, current episode moderate, without psychotic symptoms
sedative, hypnotic or anxiolytic-induced psychotic disorder
caffeine withdrawal
developmental learning disorder with impairment in reading
encopresis without constipation or overflow incontinence
unknown or unspecified psychoactive substance dependence, sustained full remission
bipolar type i disorder
synthetic cannabinoid dependence, early full remission
developmental language disorder
harmful pattern of use of nicotine, continuous
factitious disorders, unspecified
synthetic cathinone withdrawal
unspecified attention-deficit disorder
alcohol intoxication
non-24 hour sleep-wake rhythm disorder
developmental coordination disorder
major or mild neurocognitive disorder due to prion disease
histrionic personality disorder
harmful pattern of use of other specified psychoactive substance, continuous
alcohol dependence, current use, episodic
bipolar type ii disorder, currently in full remission
harmful pattern of use of synthetic cannabinoids
recurrent depressive disorder, unspecified
other specified disorders due to substance use
genito-pelvic pain disorder
bipolar type i disorder, current episode hypomanic
sedative, hypnotic, or anxiolytic intoxication
gambling disorder, unspecified
schizophrenia, first episode, unspecified
cannabis-induced anxiety disorder
other specified mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms
personality disorder
sleep-related hypoventilation due to a medication or substance
anxiety disorder induced by unknown or unspecified psychoactive substance
cluster c personality disorders
other specified delirium
disorders due to use of synthetic cathinones, unspecified
disorders due to use of synthetic cathinones
sedative, hypnotic or anxiolytic-induced delirium
bipolar type i disorder, current episode depressive, moderate with psychotic symptoms
moderate personality disorder
synthetic cathinone intoxication
alcohol dependence, unspecified
other substance–induced disorders
other specified synthetic cathinone dependence
central sleep apnoea due to high-altitude periodic breathing
episode of harmful use of volatile inhalants
gender dysphoria
secondary speech or language syndrome
alcohol-induced anxiety disorder
depersonalization/derealization disorder
mild bodily distress disorder
delirium
hallucinogen dependence, current use
developmental speech or language disorders, unspecified
secondary neurodevelopmental syndrome, unspecified
encopresis, unspecified
intoxication due to multiple specified psychoactive substances
other specified developmental speech or language disorders
synthetic cathinone-induced psychotic disorder, unspecified
propriospinal myoclonus at sleep onset
certain other specified psychoactive substance-induced mental or behavioural disorders
attention-deficit disorder
oppositional defiant disorder with chronic irritability-anger, unspecified
inhalant-related disorders
stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission
disorders due to use of unknown or unspecified psychoactive substances, unspecified
other specified mental, behavioural or neurodevelopmental disorders
dementia due to alzheimer disease with late onset
hallucinogen dependence, sustained full remission
communication disorders
single episode depressive disorder, severe, without psychotic symptoms
exhibitionistic disorder
disorders due to substance use or addictive behaviours
autism spectrum disorder with disorder of intellectual development and with impaired functional language
schizoaffective disorder, continuous, currently symptomatic
conduct-dissocial disorder, adolescent onset with limited prosocial emotions
nicotine intoxication
substance bipolar and related disorder
synthetic cathinone-induced anxiety disorder
other sedative disorders
stimulant use disorder
clinician-rated dimensions of psychosis symptom severity
gaming disorder, unspecified
harmful pattern of use of caffeine, episodic
mental or behavioural disorders associated with pregnancy, childbirth or the puerperium
opioid dependence
intellectual disability
unspecified schizophrenia spectrum and other psychotic disorder
medication-induced psychotic disorder
harmful pattern of use of synthetic cathinones
single episode depressive disorder, mild
acute and transient psychotic disorder, multiple episodes, currently symptomatic
certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders
conduct-dissocial disorder, adolescent onset with typical prosocial emotions
secondary neurocognitive syndrome
withdrawal due to unknown or unspecified psychoactive substance
harmful pattern of use of non-psychoactive substances
multiple specified psychoactive substances dependence, sustained full remission
nightmare disorder
parasomnia disorder due to a medication or substance
harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified
unspecified trauma- and stressor-related disorder
bodily distress disorder
synthetic cathinone dependence, current use
harmful pattern of use of caffeine, continuous
recurrent depressive disorder, current episode severe, with psychotic symptoms
male hypoactive sexual desire disorder
other specified behavioural or psychological disturbances in dementia
dysthymia
conduct-dissocial disorder, childhood onset, unspecified
harmful pattern of use of other specified psychoactive substance
recurrent depressive disorder, current episode, unspecified severity
dementia due to use of volatile inhalants
volatile inhalant withdrawal
dissociative drug-induced psychotic disorder including ketamine or pcp
other inhalant-induced disorders
specifier
dementia due to pellagra
nicotine dependence, current use
conduct-dissocial disorder, childhood onset with typical prosocial emotions
disinhibition in personality disorder or personality difficulty
schizotypal disorder
unspecified inhalant-related disorder
hallucinogen-induced mood disorder
schizotypal (personality) disorder
harmful pattern of use of dissociative drugs including ketamine or pcp, continuous
alcohol-induced delirium
specific learning disorder
opioid-induced mood disorder
agitation or aggression in dementia
dissociative disorders, unspecified
dsm-5 self-rated level 1 cross-cutting symptom measure—adult
obsessive-compulsive or related disorders
tic disorders
secondary mental or behavioural syndromes associated with disorders or diseases classified elsewhere
secondary obsessive-compulsive or related syndrome
postpartum depression nos
disorders of arousal from non-rem sleep, unspecified
bipolar type i disorder, current episode manic, with psychotic symptoms
synthetic cannabinoid-induced psychotic disorder
unspecified hallucinogen-related disorder
bipolar type i disorder, current episode mixed, with psychotic symptoms
conduct-dissocial disorder, unspecified
other specified gender dysphoria
disorders of bodily distress or bodily experience
harmful pattern of use of volatile inhalants, episodic
other specified mental disorder
other specified attention-deficit/hyperactivity disorder
mixed depressive and anxiety disorder
episode of harmful use of synthetic cannabinoids
harmful pattern of use of non-psychoactive substances, unspecified
other specified psychoactive substance withdrawal, unspecified
unspecified attention-deficit/hyperactivity disorder
unspecified intellectual disability
multiple specified psychoactive substances withdrawal, with seizures
unspecified hypersomnolence disorder
parasomnia disorders
cocaine-induced mood disorder
episode of harmful use of non-psychoactive substances
single episode depressive disorder, currently in partial remission
schizophrenia, multiple episodes, in full remission
female sexual arousal disorder
obsessive-compulsive and related disorder due to another medical condition
stuttering
other specified impulse control disorders
major or mild neurocognitive disorder due to another medical condition
oppositional defiant disorder without chronic irritability-anger
other specified disorders due to use of sedatives, hypnotics or anxiolytics
unspecified catatonia
body dysmorphic disorder, unspecified
personality change due to another medical condition
other specified disorders due to use of mdma or related drugs, including mda
unspecified neurodevelopmental disorder
negative symptoms in primary psychotic disorders
amnestic disorder due to use of sedatives, hypnotics or anxiolytics
cocaine intoxication
caffeine use disorder
harmful pattern of use of dissociative drugs, including ketamine or pcp, unspecified
impulse control disorder induced by other specified psychoactive substance
psychotic disorder induced by multiple specified psychoactive substances
periodic limb movement disorder
other specified dissociative disorder
other hallucinogen use disorder
recurrent depressive disorder
unspecified personality disorder
alcohol withdrawal with perceptual disturbances
restless legs syndrome
dissociative drug dependence including ketamine or pcp, current use
synthetic cannabinoid dependence, unspecified
harmful pattern of use of mdma or related drugs, including mda, unspecified
bipolar type i disorder, current episode mixed, without psychotic symptoms
catatonia induced by substances or medications
disorders specifically associated with stress, unspecified
dissociative neurological symptom disorder, with paresis or weakness
alcohol dependence, sustained partial remission
schizophrenia, continuous
attention deficit hyperactivity disorder, predominantly hyperactive-impulsive presentation
multiple specified psychoactive substances withdrawal, with perceptual disturbances
multiple specified psychoactive substances dependence, sustained partial remission
dissociative amnesia, unspecified
alcohol withdrawal, uncomplicated
dementia due to alzheimer disease, onset unknown or unspecified
impulse control disorders
disorders due to use of mdma or related drugs, including mda
acute and transient psychotic disorder, multiple episodes, in full remission
synthetic cathinone-induced delirium
cannabis dependence, early full remission
unspecified dissociative disorder
suicidal behavior disorder
central sleep apnea
cannabis withdrawal
alcohol-related disorders
acute and transient psychotic disorder, multiple episodes, unspecified
schizophrenia, first episode
other parasomnias
sedative, hypnotic or anxiolytic-induced mood disorder
psychological symptoms affecting disorders or diseases classified elsewhere
other specified somatic symptom and related disorder
hallucinogen dependence
encopresis
synthetic cannabinoid dependence, current use
harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic
stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations
mood disorder induced by unknown or unspecified psychoactive substance
single episode depressive disorder, moderate, with psychotic symptoms
body-focused repetitive behaviour disorders, unspecified
mild personality disorder
nocturnal enuresis
other specified multiple specified psychoactive substances withdrawal
catatonic disorder due to another medical condition
substance/medication-induced sexual dysfunction
hallucinogen-induced delirium
bipolar type i disorder, current episode manic, without psychotic symptoms
sleep-related hypoventilation due to medical condition
nicotine dependence, unspecified
mild neurocognitive disorder
autism spectrum disorder without disorder of intellectual development and with impaired functional language
intellectual developmental disorder
other specified mood disorders
mdma or related drug dependence, including mda, sustained full remission
alcohol-induced psychotic disorder
dementia, unknown or unspecified cause
dissociative neurological symptom disorder, with unspecified movement disturbance
primary central sleep apnoea of prematurity
disorder of intellectual development, severe
volatile inhalant dependence
body-focused repetitive behaviour disorders
harmful pattern of use of other specified psychoactive substance, episodic
dementia due to down syndrome
sleep-related movement disorder due to a medical condition
rumination disorder
developmental learning disorder, unspecified
harmful pattern of use of unknown or unspecified psychoactive substance, unspecified
opioid dependence, sustained full remission
recurrent isolated sleep paralysis
catatonia
hyperactivity disorder
other cannabis-induced disorders
schizoaffective disorder, continuous
female orgasmic disorder
sedative, hypnotic or anxiolytic withdrawal, with seizures
other specified disorders due to use of opioids
substance intoxication and withdrawal
other substance intoxication
alzheimer disease dementia, mixed type, with cerebrovascular disease
bipolar type ii disorder, current episode depressive, unspecified severity
sedative, hypnotic or anxiolytic dependence
central sleep apnoea due to a medical condition without cheyne-stokes breathing
certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
other specified disorders due to use of non-psychoactive substances
delirium, other specified cause
panic attacks in mood episodes
complex post traumatic stress disorder
other specified disorders due to addictive behaviours
secondary anxiety syndrome
short-term insomnia
disruptive behaviour or dissocial disorders
other specified harmful pattern of use of synthetic cathinones
obsessive-compulsive disorder, unspecified
harmful pattern of use of nicotine, episodic
acute and transient psychotic disorder, first episode, in full remission
parent dsm-5 level 1 cross-cutting symptom measure—child age 6–17
medication-induced anxiety disorder
schizoaffective disorder, first episode, currently symptomatic
substance-related disorders
schizoaffective disorder, multiple episodes, in full remission
parent/guardian-rated dsm-5 level 1 cross-cutting symptom measure—child age 6–17
recurrent depressive disorder, currently in partial remission
major or mild neurocognitive disorder with lewy bodies
sedative, hypnotic or anxiolytic withdrawal, uncomplicated
multiple specified psychoactive substances withdrawal, uncomplicated
certain multiple specified psychoactive substances-induced mental or behavioural disorders
confusional arousals
substance obsessive-compulsive and related disorder
disorders due to use of volatile inhalants, unspecified
dementia due to huntington disease
cannabis-induced psychotic disorder
dissociative neurological symptom disorder, with parkinsonism
alcohol dependence, early full remission
harmful pattern of use of multiple specified psychoactive substances
other specified neurodevelopmental disorders
schizophrenia, continuous, in partial remission
major neurocognitive disorder
synthetic cathinone-induced psychotic disorder
harmful pattern of use of cannabis
disruptive behaviour or dissocial disorders, unspecified
delirium induced by unknown or unspecified psychoactive substance
dissociative drug-induced delirium including ketamine or pcp
other specified anxiety disorder
anorexia nervosa with significantly low body weight, restricting pattern
anorexia nervosa, unspecified
harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous
harmful pattern of use of unknown or unspecified psychoactive substance, continuous
dementia, other specified cause
unspecified alcohol-related disorder
opioid withdrawal
synthetic cannabinoid withdrawal
dissociative drug dependence including ketamine or pcp, sustained partial remission
other (or unknown) substance withdrawal
unspecified anxiety disorder
harmful pattern of use of alcohol, episodic
synthetic cathinone-induced obsessive-compulsive or related syndrome
alcohol-induced psychotic disorder, unspecified
developmental speech sound disorder
disorders due to use of caffeine
factitious disorders
sexual sadism disorder
harmful pattern of use of non-psychoactive substances, episodic
sleep-related breathing disorders, unspecified
harmful pattern of use of hallucinogens, episodic
schizoaffective disorder, first episode, unspecified
unknown or unspecified psychoactive substance dependence
guardian-rated dsm-5 level 1 cross-cutting symptom measure—child age 6–17
multiple specified psychoactive substances dependence, unspecified
major or mild neurocognitive disorder due to huntington’s disease
other specified sleep-wake disorders
anorexia nervosa with significantly low body weight
delusional disorder, unspecified
caffeine-induced anxiety disorder
secondary mood syndrome, with manic symptoms
olfactory reference disorder
unspecified bipolar and related disorder
behavioural or psychological disturbances in dementia, unspecified
recurrent depressive disorder, currently in full remission
other hallucinogen-induced disorders
amnestic disorder due to diseases classified elsewhere
developmental speech or language disorders
mdma or related drug withdrawal, including mda
sleep terrors
harmful pattern of use of hallucinogens, unspecified
other specified personality disorder
brief psychotic disorder
other specified psychoactive substance dependence, sustained partial remission
other specified disruptive behaviour or dissocial disorders
partial dissociative identity disorder
language disorder
oppositional defiant disorder
secondary psychotic syndrome, with hallucinations and delusions
dissociative neurological symptom disorder, with speech disturbance
severe personality disorder
bipolar type ii disorder, current episode hypomanic
premenstrual dysphoric disorder
neurocognitive disorders
somatic symptom disorder
chronic insomnia
other specified elimination disorder
multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures
unspecified hyperactivity disorder
tobacco use disorder
selective mutism
harmful pattern of use of cocaine, continuous
harmful pattern of use of cocaine, unspecified
unknown or unspecified psychoactive substance dependence, current use
frontotemporal dementia
mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms, unspecified
dissociative neurological symptom disorder, with cognitive symptoms
certain specified opioid-induced mental or behavioural disorders
harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified
other neurodevelopmental disorders
cluster b personality disorders
secondary mental or behavioural syndrome, unspecified
substance/medication-induced depressive disorder
secondary personality change
delayed ejaculation
other specified schizophrenia spectrum and other psychotic disorder
unspecified anxiolytic-related disorder
harmful pattern of use of opioids, continuous
dissociative neurological symptom disorder, with facial spasm
mental disorder affecting disorders or diseases classified elsewhere
prominent anxiety symptoms in mood episodes
central sleep apnoeas
dissociative drug dependence including ketamine or pcp, unspecified
autism spectrum disorder
harmful pattern of use of opioids
schizophrenia, continuous, unspecified
impulse control disorders, unspecified
other specified parasomnias related to rem sleep
schizophreniform disorder
reactive attachment disorder
certain specified cocaine-induced mental or behavioural disorders
cocaine dependence, early full remission
disorders due to use of dissociative drugs including ketamine and phencyclidine [pcp], unspecified
dementia due to human immunodeficiency virus
sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures
body dysmorphic disorder with poor to absent insight
stimulant dependence including amphetamines, methamphetamine or methcathinone, current use
other specified schizoaffective disorder
cultural formulation interview
secondary psychotic syndrome, with hallucinations
premature ejaculation
single episode depressive disorder
schizophrenia, episode unspecified
bipolar type ii disorder, current episode depressive, moderate without psychotic symptoms
obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance
mood symptoms in dementia
dissociative amnesia
hypersomnolence disorders
disorders of intellectual development, unspecified
stimulant withdrawal including amphetamines, methamphetamine or methcathinone
mood disorder induced by multiple specified psychoactive substances
secondary mood syndrome, with unspecified symptoms
episode of harmful use of opioids
multiple specified psychoactive substances dependence, current use
obesity hypoventilation syndrome
opioid dependence, early full remission
anxiety or fear-related disorders
secondary psychotic syndrome, with delusions
compulsive sexual behaviour disorder
dissociative neurological symptom disorder, with unspecified symptoms
harmful pattern of use of cocaine
psychological factors affecting other medical conditions
stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
depersonalization-derealization disorder
dissociative neurological symptom disorder, with dystonia
synthetic cathinone dependence, sustained full remission
unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified
gambling disorder
dissociative neurological symptom disorder, with chorea
conduct-dissocial disorder, childhood onset
dissociative neurological symptom disorder, with other sensory disturbance
personality disorder, severity unspecified
premature (early) ejaculation
factitious disorder imposed on another
gaming disorder
disorders due to use of sedatives, hypnotics or anxiolytics, unspecified
harmful pattern of use of unknown or unspecified psychoactive substance, episodic
bipolar type i disorder, unspecified
schizophrenia, multiple episodes, currently symptomatic
obsessive-compulsive personality disorder
genito-pelvic pain/penetration disorder
avoidant food intake disorder
hallucinogen-related disorders
schizoaffective disorder, multiple episodes, in partial remission
disorders due to use of other specified psychoactive substances, including medications, unspecified
developmental language disorder, with other specified language impairment
bipolar type i disorder, current episode depressive, unspecified severity
cannabis use disorder
harmful use of synthetic cathinones, continuous
medication-induced obsessive-compulsive and related disorder
synthetic cannabinoid-induced mood disorder
disorders due to substance use, unspecified
sleep-related hypoxemia due to a medical condition
opioid dependence, sustained partial remission
parasomnia disorders, unspecified
dementia due to use of alcohol
withdrawal due to unknown or unspecified psychoactive substance, uncomplicated
harmful pattern of use of sedatives, hypnotics or anxiolytics
coercive sexual sadism disorder
hypersomnolence disorder
nocturnal and diurnal enuresis
recurrent depressive disorder, current episode mild
mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, with psychotic symptoms
harmful pattern of use of cannabis, continuous
transvestic disorder
unspecified disruptive, impulse-control, and conduct disorder
sleepwalking disorder
delusional disorder, in full remission
bipolar type ii disorder, current episode depressive, mild
other sedative-, hypnotic-, or anxiolytic-induced disorders
tobacco withdrawal
nicotine withdrawal
stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified
intoxication due to unknown or unspecified psychoactive substance
obstructive sleep apnoea
opioid-induced anxiety disorder
hoarding disorder, unspecified
substance sleep disorder
volatile inhalant dependence, early full remission
harmful pattern of use of synthetic cathinones, episodic
dementia due to parkinson disease
single episode depressive disorder, currently in full remission
attention deficit hyperactivity disorder, presentation unspecified
substance/medication-induced anxiety disorder
depressive disorders, unspecified
other specified sleep-related movement disorders
depressive episodes with short-duration hypomania
harmful pattern of use of cannabis, episodic
caffeine-related disorders
schizophrenia or other primary psychotic disorders
delirium due to multiple etiological factors
other specified disorders due to use of synthetic cathinones
other alcohol-induced disorders
paraphilic disorders
hypnagogic exploding head syndrome
disorders due to use of caffeine, unspecified
dementia due to alzheimer disease with early onset
other specified disorders due to use of cannabis
bipolar type ii disorder
synthetic cathinone dependence
stimulant intoxication
symptomatic manifestations of primary psychotic disorders
acute and transient psychotic disorder
disorders of bodily distress or bodily experience, unspecified
other stimulant-induced disorders
other specified disorders due to use of caffeine
other specified neurocognitive disorders
delirium, unspecified or unknown cause
sleep-related bruxism
anorexia nervosa with dangerously low body weight, unspecified
disorders due to use of cocaine, unspecified
mental, behavioural or neurodevelopmental disorders
medication-induced sexual dysfunction
circadian rhythm sleep-wake disorders
disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
agoraphobia
secondary neurodevelopmental syndrome
hypersomnia associated with a mental disorder
amnestic disorder, other specified cause
generalised anxiety disorder
cannabis dependence, sustained partial remission
disorders due to use of non-psychoactive substances
harmful pattern of use of alcohol
pedophilic disorder
mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, unspecified
persistent (chronic) motor or vocal tic disorder
harmful pattern of use of multiple specified psychoactive substances, continuous
impulse control disorder induced by unknown or unspecified psychoactive substance
dementia due to normal pressure hydrocephalus
cannabis-related disorders
conduct disorder
obsessive-compulsive disorder with fair to good insight
cocaine-induced psychotic disorder, unspecified
other substance–related disorders
acute and transient psychotic disorder, unspecified
bodily distress disorder, unspecified
other opioid-induced disorders
oppositional defiant disorder with chronic irritability-anger
withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances
sleep-related breathing disorders
paranoid personality disorder
substance-induced disorders
harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
anxiety disorder induced by multiple specified psychoactive substances
harmful pattern of use of caffeine
harmful pattern of use of nicotine, unspecified
other caffeine-induced disorders
disorders due to use of alcohol
caffeine intoxication
disorders due to use of unknown or unspecified psychoactive substances
other specified disorders due to use of nicotine
other specified central sleep apnoeas
avoidant-restrictive food intake disorder
synthetic cannabinoid-induced anxiety disorder
volatile inhalant dependence, sustained partial remission
other substance withdrawal
stereotyped movement disorder
disorders due to substance use
anorexia nervosa with dangerously low body weight, restricting pattern
other specified primary psychotic disorder
factitious disorder
other specified insomnia disorder
enuresis, unspecified
cultural formulation interview (cfi)—informant version
other specified secondary mental or behavioural syndrome
apathy in dementia
oppositional defiant disorder with chronic irritability-anger with limited prosocial emotions
schizoaffective disorder, continuous, in full remission
positive symptoms in primary psychotic disorders
other tobacco-induced disorders
episode of harmful use of other specified psychoactive substance
other specified disorders of bodily distress or bodily experience
non-congenital central hypoventilation with hypothalamic abnormalities
hallucinogen dependence, unspecified
other specified disorders due to use of hallucinogens
synthetic cannabinoid dependence, sustained partial remission
dissociative neurological symptom disorder, with myoclonus
substance/medication-induced bipolar and related disorder
cannabis dependence, current use
amnestic disorder due to use of alcohol
disorders of intellectual development
other specified hypersomnolence disorder
developmental learning disorder
secondary mood syndrome, with depressive symptoms
mood disorders, unspecified
restrictive food intake disorder
sedative, hypnotic or anxiolytic dependence, early full remission
unknown or unspecified psychoactive substance dependence, sustained partial remission
volatile inhalant dependence, unspecified
dissociative neurological symptom disorder, with other specified movement disturbance
other specified bipolar or related disorders
stimulant withdrawal
cannabis dependence
harmful pattern of use of alcohol, unspecified
hallucinogen intoxication
sedative-, hypnotic-, or anxiolytic-related disorders
schizoid personality disorder
maladaptive health behaviours affecting disorders or diseases classified elsewhere
harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic
medication-induced depressive disorder
other specified autism spectrum disorder
opioid use disorder
delirium induced by multiple specified psychoactive substances including medications
dissociative neurological symptom disorder, with gait disturbance
cannabis dependence, unspecified
feeding or eating disorders
hypochondriasis
other specified trauma- and stressor-related disorder
dissociative neurological symptom disorder, with auditory disturbance
other specified psychoactive substance intoxication
schizophrenia, first episode, in full remission
stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
catatonia, unspecified
provisional tic disorder
bipolar type i disorder, currently in partial remission, most recent episode depressive
elimination disorders, unspecified
unspecified neurocognitive disorder
sedative, hypnotic or anxiolytic dependence, unspecified
unknown or unspecified psychoactive substance dependence, early full remission
mdma or related drug dependence, including mda, current use
global developmental delay
sleepwalking
other hypnotic disorders
alcohol-induced psychotic disorder with mixed psychotic symptoms
withdrawal due to unknown or unspecified psychoactive substance, with seizures
current depressive episode persistent
disorders due to use of opioids, unspecified
other specified neurodevelopmental disorder
multiple specified psychoactive substances dependence, early full remission
cocaine-induced anxiety disorder
unspecified stimulant-related disorder
other personality disorders
synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms
oppositional defiant disorder without chronic irritability-anger, unspecified
stereotypic movement disorder
alcohol withdrawal with seizures
psychological or behavioural factors affecting disorders or diseases classified elsewhere
alcohol dependence
schizoaffective disorder
sleep-related eating disorder
other specified disorders specifically associated with stress
paraphilic disorder involving solitary behaviour or consenting individuals
other specified disorders due to use of dissociative drugs including ketamine and phencyclidine [pcp]
gaming disorder, predominantly offline
specific phobia
opioid intoxication
disorders due to use of synthetic cannabinoids
alcohol use disorder
sedative, hypnotic or anxiolytic withdrawal
other specified dissociative disorders
disorders due to use of cannabis, unspecified
advanced sleep-wake phase disorder
mental, behavioural or neurodevelopmental disorders, unspecified
dissociative disorders
other specified episode of schizophrenia
stimulant dependence including amphetamines, methamphetamine or methcathinone
unspecified paraphilic disorde
amnestic disorder
volatile inhalant dependence, current use
sedative, hypnotic or anxiolytic dependence, current use
bipolar type ii disorder, currently in partial remission, most recent episode hypomanic
encopresis with constipation or overflow incontinence
schizophrenia, multiple episodes, in partial remission
dementia due to other specified diseases classified elsewhere
stimulant-related disorders
mdma or related drug dependence, including mda, unspecified
medication-induced major or mild neurocognitive disorder
avoidant/restrictive food intake disorder
disorders due to use of volatile inhalants
central sleep apnoea due to a medication or substance
anxiety disorder due to another medical condition
sedative, hypnotic or anxiolytic intoxication
unspecified tobacco-related disorder
anorexia nervosa with significantly low body weight, unspecified
nicotine dependence, sustained partial remission
bipolar type ii disorder, current episode depressive, severe with psychotic symptoms
speech sound disorder
other specified psychoactive substance withdrawal, with perceptual disturbances
nonsuicidal self-injury
other specified bipolar type i disorder
secondary psychotic syndrome, with unspecified symptoms
cocaine-induced delirium
persistent motor or vocal tic disorder
schizotypal personality disorder
psychotic disorder induced by unknown or unspecified psychoactive substance
bipolar type i disorder, currently in full remission
disorders due to use of opioids
alzheimer disease dementia, mixed type, with other nonvascular aetiologies
disorders due to use of cocaine
schizoaffective disorder, continuous, in partial remission
dementia due to prion disease
symptomatic and course presentations for mood episodes in mood disorders
other specified mental disorder due to another medical condition
female sexual interest disorder
episode of harmful use of dissociative drugs including ketamine or pcp
anxiety or fear-related disorders, unspecified
stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone
personality traits or coping style affecting disorders or diseases classified elsewhere
certain specified mdma or related drug-induced mental or behavioural disorders, including mda
sleep-related hypoventilation or hypoxemia disorders, unspecified
other specified sexual dysfunction
mdma or related drug intoxication, including mda
certain specified caffeine-induced mental or behavioural disorders
delirium due to unknown or unspecified aetiological factors
episode of harmful use of unknown or unspecified psychoactive substances
synthetic cathinone dependence, sustained partial remission
social communication disorder
insomnia disorder
inhalant use disorder
obsessive-compulsive or related disorder induced by other specified psychoactive substance
unspecified gender dysphoria
hypochondriasis with poor to absent insight
other specified psychoactive substance withdrawal, uncomplicated
unspecified delirium
dissociative identity disorder
oppositional defiant disorder without chronic irritability-anger with limited prosocial emotions
volatile inhalant-induced delirium
catatonia specifier
unspecified mental disorder
stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone
unspecified tic disorder
other specified sleep-wake disorder
social (pragmatic) communication disorder
synthetic cathinone dependence, unspecified
mdma or related drug-induced anxiety disorder
diurnal enuresis
developmental language disorder with impairment of mainly pragmatic language
synthetic cannabinoid dependence, sustained full remission
anxiolytic-related disorders
rem sleep behaviour disorder
panic disorder
other specified disorders due to use of synthetic cannabinoids
disorders due to use of dissociative drugs including ketamine and phencyclidine [pcp]
other specified psychoactive substance dependence, early full remission
posttraumatic stress disorder
stereotyped movement disorder with self-injury
dissociative drug-induced mood disorder including ketamine or pcp
synthetic cannabinoid dependence
sedative, hypnotic or anxiolytic-induced anxiety disorder
other specified hypersomnolence disorders
other specified sleep-related hypoventilation or hypoxemia disorders
conduct-dissocial disorder, adolescent onset
unspecified other substance–related disorder
non–rapid eye movement sleep arousal disorders
dissociative neurological symptom disorder, with movement disturbance
cannabis-induced mood disorder
cross-cutting symptom measures
olfactory reference disorder, unspecified
narcolepsy, type 2
other specified secondary neurodevelopmental syndrome
harmful pattern of use of caffeine, unspecified
major or mild frontotemporal neurocognitive disorder
voyeuristic disorder
mood disorder induced by other specified psychoactive substance
disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified
dependent personality disorder
schizoaffective disorder, multiple episodes, currently symptomatic
hypochondriasis with fair to good insight
dissociative amnesia with dissociative fugue
other specified psychological or behavioural factors affecting disorders or diseases classified elsewhere
sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances
dementia due to psychoactive substances including medications
developmental learning disorder with other specified impairment of learning
adjustment disorders
delirium induced by other specified psychoactive substance including medications
episode of harmful use of alcohol
stereotyped movement disorder without self-injury
treatment-emergent central sleep apnoea
generalized anxiety disorder
borderline pattern
schizoaffective disorder, unspecified
developmental language disorder with impairment of mainly expressive language
harmful pattern of use of multiple specified psychoactive substances, episodic
hair-pulling disorder
mdma or related drug dependence, including mda, early full remission
intermittent explosive disorder
genito-pelvic penetration disorder
major or mild neurocognitive disorder due to traumatic brain injury
substance depressive disorder
multiple specified psychoactive substances dependence
disorders due to addictive behaviours
schizoaffective disorder, first episode
autism spectrum disorder with disorder of intellectual development and with absence of functional language
parasomnias related to rem sleep, unspecified
other specified psychoactive substance dependence
developmental language disorder with impairment of receptive and expressive language
acute and transient psychotic disorder, first episode, unspecified
disorders due to use of synthetic cannabinoids, unspecified
harmful use of mdma or related drugs, including mda, continuous
other (or unknown) substance–related disorders
other specified bipolar and related disorder
unspecified feeding or eating disorder
dementia
other specified body-focused repetitive behaviour disorders
other specified psychoactive substance dependence, current use
borderline personality disorder
bipolar type ii disorder, unspecified
psychotic disorder due to another medical condition
disorders due to addictive behaviours, unspecified
post traumatic stress disorder
harmful pattern of use of volatile inhalants, unspecified
schizoaffective disorder, multiple episodes, unspecified
disinhibited social engagement disorder
obstructive sleep apnea hypopnea
mdma or related drug-induced delirium, including mda
rapid eye movement sleep behavior disorder
hypochondriasis, unspecified
elimination disorders
episode of harmful use of cocaine
primary central sleep apnoea
disorders due to use of multiple specified psychoactive substances, including medications, unspecified
cognitive symptoms in primary psychotic disorders
unspecified phencyclidine-related disorder
delusional disorder, in partial remission
unspecified insomnia disorder
disorders due to use of hallucinogens, unspecified
previously phonological disorder
bipolar and related disorder due to another medical condition
cannabis-induced delirium
dysthymic disorder
alcohol dependence, current use, continuous
episode of harmful use of cannabis
substance/medication-induced sleep disorder
substance/medication-induced psychotic disorder
episode of harmful use of nicotine
other paraphilic disorder involving non-consenting individuals
derealization disorder
non-substance-related disorders
dementia due to multiple sclerosis
episode of harmful use of hallucinogens
disorders due to use of mdma or related drugs, including mda, unspecified
anxiety disorder induced by other specified psychoactive substance
other specified feeding or eating disorder
other specified obsessive-compulsive and related disorder
attention-deficit/hyperactivity disorder
bipolar type ii disorder, currently in partial remission, most recent episode depressive
hypersomnolence disorders, unspecified
harmful pattern of use of synthetic cannabinoids, continuous
other specified obsessive-compulsive or related disorders
dissociative neurological symptom disorder, with visual disturbance
alcohol withdrawal with perceptual disturbances and seizures
medication-induced mental disorders
neurodevelopmental disorders, unspecified
stress-related physiological response affecting disorders or diseases classified elsewhere
alcohol-induced psychotic disorder with hallucinations
secondary dissociative syndrome
synthetic cathinone-induced mood disorder
other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
hypersomnia due to a medication or substance
sedative, hypnotic or anxiolytic withdrawal, unspecified
bipolar type i disorder, currently in partial remission, most recent episode unspecified
cocaine-induced psychotic disorder
conduct-dissocial disorder, childhood onset with limited prosocial emotions
depressive mood symptoms in primary psychotic disorders
bipolar type ii disorder, currently in partial remission, most recent episode unspecified
hallucinogen dependence, early full remission
volatile inhalant-induced psychotic disorder
major or mild neurocognitive disorder due to multiple etiologies
dissociative drug intoxication including ketamine or pcp
sleep-related leg cramps
major or mild vascular neurocognitive disorder
disorders of arousal from non-rem sleep
nicotine dependence
harmful pattern of use of unknown or unspecified psychoactive substance
harmful pattern of use of dissociative drugs, including ketamine or pcp
synthetic cannabinoid intoxication
rumination-regurgitation disorder
cluster a personality disorders
disorder of intellectual development, mild
impulse control syndrome induced by multiple specified psychoactive substances
sleep-related movement disorder due to a medication or substance
other specified disorders due to use of volatile inhalants
body integrity dysphoria
cocaine-induced psychotic disorder with hallucinations
obsessive-compulsive disorder
other specified disorders due to use of alcohol
schizophrenia, first episode, in partial remission
substance/medication-induced obsessive-compulsive and related disorder
acute and transient psychotic disorder, multiple episodes
developmental learning disorder with impairment in mathematics
dementia due to lewy body disease
amnestic disorder due to psychoactive substances including medications
other specified depressive disorders
depressive disorders
idiopathic central alveolar hypoventilation
excoriation (skin-picking) disorder
developmental learning disorder with impairment in written expression
seasonal pattern of mood episode onset
stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
alcohol-induced mood disorder
other specified acute and transient psychotic disorder
sedative, hypnotic, or anxiolytic withdrawal
mood disorders
other anxiolytic-induced disorders
schizophrenia, first episode, currently symptomatic
hallucinogen-induced anxiety disorder
phencyclidine use disorder
sleep-related movement disorders
world health organization disability assessment schedule 2.0
unspecified depressive disorder
behavioural or psychological disturbances in dementia
unspecified other (or unknown) substance–related disorder
circadian rhythm sleep-wake disorder, shift work type
adjustment disorder
sleep-related hypoventilation or hypoxemia disorders
sleep-related rhythmic movement disorder
mdma or related drug-induced mood disorder, including mda
bipolar ii disorder
delirium due to disease classified elsewhere
other specified synthetic cannabinoid dependence
central sleep apnoeas, unspecified
other specified disruptive, impulse-control, and conduct disorder
anorexia nervosa with dangerously low body weight
tobacco-related disorders
pica
kleine-levin syndrome
disorders due to use of other specified psychoactive substances, including medications
unspecified somatic symptom and related disorder
sleep-related hypoventilation
mdma or related drug dependence, including mda
dissociative drug dependence including ketamine or pcp, early full remission
schizophrenia, multiple episodes, unspecified
amnestic disorder due to use of volatile inhalants
obsessive-compulsive or related disorders, unspecified
personality disorders and related traits
dementia due to other specified psychoactive substance
dementia due to cerebrovascular disease
narcissistic personality disorder
pyromania
synthetic cannabinoid-induced delirium
opioid-induced psychotic disorder
olfactory reference disorder with poor to absent insight
harmful pattern of use of nicotine
dissociality in personality disorder or personality difficulty
other hallucinogen intoxication
oppositional defiant disorder without chronic irritability-anger with typical prosocial emotions
stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone
other (or unknown) substance use disorder
alcohol-induced psychotic disorder with delusions
parasomnias related to rem sleep
harmful use of mdma or related drugs, including mda, episodic
bipolar or related disorders
social phobia
unspecified caffeine-related disorder
sedative anxiolytic-related disorders
delusional disorder
unspecified hypnotic disorder
whodas 2.0
alcohol dependence, sustained full remission
fetishistic disorder
oppositional defiant disorder with chronic irritability-anger with typical prosocial emotions
acute and transient psychotic disorder, first episode, in partial remission
episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
bipolar i disorder
cocaine-induced psychotic disorder with delusions
excoriation disorder
dissociative neurological symptom disorder, with non-epileptic seizures
erectile disorder
irregular sleep-wake rhythm disorder
hypersomnia due to a medical condition
psychological or behavioural factors affecting disorders or diseases classified elsewhere, unspecified
bipolar type i disorder, currently in partial remission, most recent episode mixed
disorders due to use of nicotine
acute and transient psychotic disorder, multiple episodes, in partial remission
gambling disorder, predominantly online
synthetic cathinone-induced psychotic disorder with delusions
episode of harmful use of synthetic cathinones
schizophrenia, continuous, in full remission
frotteuristic disorder
stereotyped movement disorder, unspecified
dissociative neurological symptom disorder, with tremor
volatile inhalant intoxication
disorders due to use of nicotine, unspecified
withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures
possession trance disorder
hallucinogen-induced psychotic disorder
sedative, hypnotic, or anxiolytic use disorder
unspecified opioid-related disorder
certain specified hallucinogen-induced mental or behavioural disorders
other specified anxiety or fear-related disorders
disorders due to use of hallucinogens
attenuated psychosis syndrome
cocaine dependence, unspecified
dissociative drug dependence including ketamine or pcp
substance/medication-induced mental disorders
other specified parasomnia disorders
cocaine withdrawal
dissociative neurological symptom disorder, with other specified symptoms
other specified recurrent depressive disorder
cyclothymic disorder
narcolepsy, type 1
secondary mood syndrome, with mixed symptoms
secondary psychotic syndrome
volatile inhalant dependence, sustained full remission
internet gaming disorder
harmful pattern of use of hallucinogens
general personality disorder
other substance use disorder
dementia due to alzheimer disease
cocaine dependence, sustained full remission
insufficient sleep syndrome
delusional disorder, currently symptomatic
current depressive episode with melancholia
harmful pattern of use of synthetic cannabinoids, episodic
other specified attention-deficit disorder
other phencyclidine-induced disorders
harmful pattern of use of synthetic cannabinoids, unspecified
conversion disorder
single episode depressive disorder, severe, with psychotic symptoms
attention deficit hyperactivity disorder, predominantly inattentive presentation
acute stress disorder
schizoaffective disorder, continuous, unspecified
disorders due to use of cannabis
major or mild neurocognitive disorder due to alzheimer’s disease
sexual masochism disorder
substance sexual dysfunction
major or mild neurocognitive disorder due to parkinson’s disease
unspecified elimination disorder
phencyclidine intoxication
developmental speech fluency disorder
prominent personality traits or patterns
manic mood symptoms in primary psychotic disorders
certain specified synthetic cathinone-induced mental or behavioural disorders
other specified psychoactive substance withdrawal, with seizures
dissociative drug dependence including ketamine or pcp, sustained full remission
single episode depressive disorder, moderate, without psychotic symptoms
episode of harmful use of caffeine
opioid-related disorders
hallucinogen dependence, sustained partial remission
other specified hyperactivity disorder
anankastia in personality disorder or personality difficulty
bipolar type ii disorder, current episode depressive, severe without psychotic symptoms
persistent complex bereavement disorder
benign sleep myoclonus of infancy
disorder of intellectual development, moderate
bipolar type i disorder, current episode depressive, mild
certain specified synthetic cannabinoids-induced mental or behavioural disorders
substance anxiety disorder
secondary mood syndrome
synthetic cathinone-induced impulse control disorder
gambling disorder, predominantly offline
autism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language
mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms
body dysmorphic disorder
amnestic disorder due to unknown or unspecified aetiological factors
bipolar type i disorder, current episode depressive, moderate without psychotic symptoms
sleep-related hallucinations
body dysmorphic disorder with fair to good insight
acute and transient psychotic disorder, first episode
anxiety symptoms in dementia
multiple specified psychoactive substances withdrawal, unspecified
intellectual disabilities
factitious disorder imposed on self
bipolar type i disorder, current episode depressive, severe without psychotic symptoms
unspecified sedative-, hypnotic-, or anxiolytic-related disorder
gaming disorder, predominantly online
harmful pattern of use of opioids, episodic
anorexia nervosa with dangerously low body weight, binge-purge pattern
other specified disorders of arousal from non-rem sleep
other specified bipolar type ii disorder
unspecified mental disorder due to another medical condition
primary central sleep apnoea of infancy
rapid cycling
secondary catatonia syndrome
separation anxiety disorder
narcolepsy, unspecified
olfactory reference disorder with fair to good insight
dissociative neurological symptom disorder
hoarding disorder with fair to good insight
depersonalization disorder
delayed sleep-wake phase disorder
bipolar type i disorder, current episode depressive, severe with psychotic symptoms
tourette’s disorder
conduct-dissocial disorder
other (or unknown) substance–induced disorders
insomnia disorders, unspecified
anorexia nervosa
